A fridge failure and how I assessed the contents afterwards

A fridge failure and how I assessed the contents afterwards Writing it up because I had to work it out twice and would rather nobody else did.

I have read the maintained page on this and I still have a gap, so I am asking rather than guessing.

Context: tirzepatide, 25 weeks in, currently at a dose I reached by the standard four-week steps. Everything below is my own record rather than anything a clinician told me.

The specific question is the one in the title. What I have already checked: the labelling summary on the relevant documentation page, the two most-linked topics in this subcategory, and my own notes from the last 7 weeks. What I could not find is whether the answer changes at higher doses or whether it is the same arithmetic throughout.

If the answer is "it depends", I would rather know what it depends on than be given a number.

Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most stability claims assume refrigeration.

Coming back to the opening post, because the follow-up matters more than the original answer.

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

Picking up the opening post: that is the part I would want checked first.

Shipping container and cold packs: reputable suppliers use insulated containers with cold packs designed to arrive cool. Checking on arrival that cold packs are still cold is a sign the chain was maintained.

Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.

Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room temperature risks degradation.

I read post #5 twice before replying, because I had assumed the opposite.

Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with ice packs are common solutions.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual temperature; some are warmer than the label.

post #9 answers the question as asked. The question underneath it is different.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

post #10 is right about the mechanism and I think understates the practical bit.

Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its original packaging (often opaque) usually suffices.

Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about excursion.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

I read post #12 twice before replying, because I had assumed the opposite.

Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible does not mean not damaged, but visible problems are a reason to contact the supplier.